Smartphone program aims to boost hope and recovery in oral cancer survivors

NCT ID NCT07714967

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a mobile-based rehabilitation program, built on the PERMA-H model of well-being, can improve hope, self-confidence, and social support in people recovering from a tracheostomy due to oral cancer. Participants use a WeChat mini-program with a chatbot and tailored modules. The goal is to see if this digital tool leads to better psychological and functional outcomes compared with standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a mobile-based rehabilitation support program using the PERMA-H model and a chatbot
What this could lead to
If effective, this program could provide a scalable, low-cost way to improve psychological well-being and recovery outcomes for oral cancer patients after tracheostomy.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply broadly. The intervention relies on mobile technology, which may not suit all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥18 years * Pathologically diagnosed with oral squamous cell carcinoma and undergoing, or scheduled to undergo, tracheostomy followed by decannulation * Fully conscious, with a Glasgow Coma Scale score of 15, and able to successfully complete the Three-Step Command Test, indicating intact comprehension ability * Able to communicate effectively through verbal speech or alternative methods, including writing, gestures, electronic device input, or voice-assisted tools * Able to use WeChat independently or after brief guidance, without communication barriers * Has at least one regular family caregiver; both the patient and caregiver fully understand the study content and voluntarily provide written informed consent * Free from severe cardiovascular, cerebrovascular, hepatic, renal, or pulmonary disease Exclusion Criteria: * Presence of other serious malignancies or extensive tumor metastasis * Previous or current diagnosis of severe mental illness, such as schizophrenia or severe bipolar disorder * Significant cognitive impairment, severe depressive symptoms, or suicide risk that precludes effective participation in psychological interventions * Inability to complete assessments or interventions due to severe hearing, visual, or language impairments * Inability to communicate effectively through any available alternative means * Lack of access to a smartphone and absence of a designated caregiver * Explicit unwillingness or inability to use a mobile-based rehabilitation support program * Unexpected inability to complete the full intervention cycle, including planned hospital transfer or prolonged loss to follow-up * Concurrent participation in other clinical studies primarily focused on psychological or mobile health interventions that could confound study outcomes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Decanulation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mouth Neoplasms oral cavity squamous cell carcinoma psychiatric disorder Psychological Well-Being Speech Intelligibility Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Affiliated Hospital of University of Malaya

    Kuala Lumpur, Kuala Lumpur, Malaysia

  • The Second Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.